Pickup,
C.
J.
O.:—This
is
an
appeal
by
a
son
of
the
deceased
from
a
Judgment
pronounced
by
McLennan,
J.,
in
Weekly
Court,
on
an
application
made
to
him
by
the
executor
and
trustee
of
the
last
will
and
testament
of
Stella
Maud
Waters,
deceased,
to
determine
whether
certain
3%
non-cumulative
redeemable
preference
shares
of
the
capital
stock
of
Dodds
Medicine
Company
Limited
(which
company
I
shall
refer
to
as
the
company)
received
by
the
executor
as
a
stock
dividend
on
February
19,
1951,
or
the
redemption
monies
representing
such
part
of
the
said
shares
as
have
been
redeemed,
are
capital
or
income
in
the
estate
of
the
said
deceased.
The
learned
Judge
in
Weekly
Court
held
that
such
dividend
and
redemption
monies
were
capital
and
not
income.
The
appellant
contends
that
such
dividend
and
redemption
monies
should
have
been
held
to
be
income
and
not
capital.
Stella
Maud
Waters
died
on
July
15,
1940,
and
by
her
will
devised
her
estate
to
her
trustees
upon
trust
to
pay
income
to
her
son
and
daughter
for
life
with
remainder
to
them
in
certain
events,
failing
which
the
capital
is
to
be
divided
into
two
equal
shares
to
be
held
in
trust
for
two
grandsons
with
cross-remainders
between
them
and
an
ultimate
contingent
remainder.
Among
the
original
assets
of
the
estate,
are
8,000
common
shares
of
the
capital
stock
of
the
company
out
of
a
total
authorized
capital
of
30,000
shares.
At
the
time
of
the
events
hereinafter
mentioned,
all
of
the
30,000
shares
of
authorized
capital
had
been
issued.
I
find
nothing
in
the
will
of
the
deceased
which
would
determine
whether
the
dividend
or
redemption
monies
in
question
would
go
to
beneficiaries
entitled
to
income
or
to
beneficiaries
entitled
to
capital,
and
the
question
involved
in
this
appeal
falls
to
be
determined
by
law
without
any
assistance
from
the
will
of
the
deceased.
As
this
question
of
fact
depends
upon
the
corporate
acts
of
the
company
and
upon
them
alone,
it
is
necessary
to
review
in
some
detail
the
corporate
proceedings.
On
October
19,
1950,
in
annual
meeting
of
shareholders,
the
chairman
made
the
following
report
to
the
meeting:
“9.
The
chairman
stated
that
the
directors
had
given
consideration
to
the
recent
amendments
in
the
Income
Tax
Act
and
felt
that
the
company
should
elect
to
proceed
under
Section
95(a)
of
that
Act
to
pay
a
15%
tax
on
the
undistributed
income
of
the
company
on
hand
at
April
30,
1949,
and
also
on
an
amount
equal
to
the
dividends
paid
by
the
company
during
its
taxation
year,
which
ended
April
30,
1950.
The
undistributed
income
at
April
30,
1949,
is
estimated
by
the
company’s
auditors
at
$248,623.58.
The
amount
of
dividends
paid
by
the
company
in
the
year
ended
April
30,
1950,
was
$39,900,
total
$288,523.58.
Fifteen
per
cent
tax
thereon
amounts
to
$43,278.54,
which
would
leave
the
sum
of
$254,245.04
in
the
hands
of
the
company
on
which
taxes
would
have
been
paid.
It
is
suggested
that
$240,000
of
this
amount
be
placed
in
the
hands
of
the
shareholders
by
creating
$500,000
par
value
preference
shares
in
the
company
and
issuing
$240,000
par
value
of
such
shares
to
the
present
shareholders
by
way
of
stock
dividend.
This
would
mean
that
the
present
holders
of
the
common
stock
of
the
company
would
receive
$8
par
value
in
preference
shares
for
each
common
share
now
held.
The
company
could
then
redeem
these
preference
shares
from
time
to
time
and
the
amount
of
the
redemption
price
would
not
be
taxable
in
the
hands
of
the
shareholders.’’
Whereupon,
the
shareholders
passed
the
following
resolutions:
“Upon
motion
duly
made
and
seconded
it
was
resolved
that
the
Dodds
Medicine
Company
Limited
elects
under
subsection
(1)
of
Section
95A
of
the
Income
Tax
Act
to
be
assessed
and
to
pay
a
tax
on
an
amount
equal
to
its
undistributed
income
on
hand
at
the
end
of
the
1949
taxation
year,
namely
April
30,
1949.
10.
Upon
motion
duly
made
and
seconded
it
was
resolved
that
after
the
company
has
been
assessed
under
Section
95A
(1)
of
the
Income
Tax
Act
and
has
paid
the
tax
payable
under
the
said
subsection,
the
directors
be
and
they
are
hereby
authorized
from
time
to
time
to
elect
on
behalf
of
the
company
or
cause
the
company
to
elect
to
be
assessed
and
to
pay
a
tax
of
15%
on
an
amount
not
exceeding
the
aggregate
of
the
dividends
declared
and
paid
by
the
company
in
any
taxation
year
beginning
with
the
1950
taxation
year
and
ending
with
the
last
complete
taxation
year
before
such
election.
11.
Upon
motion
duly
made
and
seconded
it
was
resolved
that
the
directors
and
officers
be
authorized
to
proceed
with
such
steps
as
may
be
necessary
to
increase
the
authorized
capital
of
the
company
by
the
creation
of
preference
shares
of
the
company
of
a
par
value
of
$500,000.’’
On
November
28,
1950,
the
directors
of
the
company
passed
two
by-laws,
being
by-laws
Nos.
30
and
31,
both
of
which
were
duly
ratified
and
confirmed
by
the
shareholders
on
December
11,
1950.
By-law
No.
30,
in
part,
reads
as
follows:
“WHEREAS
the
authorized
capital
of
the
Dodds
Medicine
Company
Limited
(hereinafter
called
‘the
company’),
now
consists
of
30,000
shares
without
any
nominal
or
par
value,
all
of
which
shares
have
been
issued
and
are
fully
paid
and
are
outstanding
:
AND
WHEREAS
it
is
deemed
advisable
to
increase
the
capital
of
the
company
by
the
creation
of
500,000
non-cumu-
lative
non-voting
preference
shares
of
the
par
value
of
$1
per
share
;
NOW
THEREFORE
BE
IT
ENACTED
as
a
by-law
of
the
company
:
A.
THAT
the
capital
of
the
company
be
and
the
same
is
hereby
increased
by
the
creation
of
500,000
non-voting
preference
shares
of
a
par
value
of
$1
each
and
the
said
preference
shares
shall
be
issued
and
allotted
by
the
directors
from
time
to
time
as
they
may
determine.
’
’
I
do
not
quote
the
remainder
of
this
by-law.
It
is
sufficient
to
say
that
the
by-law
sets
forth
the
preferences,
priorities,
rights,
privileges,
limitations
and
conditions
applicable
to
the
preference
shares.
Under
these
provisions
contained
in
the
by-law,
the
holders
of
preference
shares
were
entitled
to
receive
yearly
non-
cumulative
preferential
dividends
at
the
rate
of
3%
per
annum
;
in
the
event
of
liquidation,
bankruptcy,
dissolution,
winding-up
or
reorganization
of
the
company,
or
other
distribution
of
the
assets
of
the
company
among
shareholders
by
way
of
return
of
capital,
the
holders
of
these
preference
shares
were
entitled
to
receive
the
par
value
thereof,
plus
declared
and
unpaid
dividends
computed
to
date
of
distribution
in
priority
to
distribution
of
monies
or
assets
among
the
holders
of
common
shares;
the
preference
shares
were
to
be
redeemable
in
whole
or
in
part,
without
premium,
at
any
time
and
from
time
to
time
upon
notice
in
accordance
with
the
redemption
conditions
contained
in
the
bylaw.
The
company
was
to
have
the
right
to
purchase
for
cancellation
the
whole
or
from
time
to
time
any
part
of
the
outstanding
shares
in
the
market
or
by
private
contract
in
accordance
with
the
provisions
contained
in
the
by-law,
and
shares
so
purchased
would
thereupon
be
cancelled
and
could
not
be
reissued.
The
by-law
also
authorized
application
to
His
Honour
the
Lieutenant-Governor
of
the
Province
of
Ontario
for
supplementary
letters
patent
confirming
the
by-law.
Pursuant
to
this
authorization,
supplementary
letters
patent
were
issued
on
December
12,
1950
designating
the
previously
issued
30,000
shares
of
the
capital
stock
of
the
company
as
common
shares
and
increasing
the
capital
of
the
company
in
accordance
with
the
terms
of
by-law
No.
30.
By-law
No.
31
need
not
be
quoted.
It
simply
provided
that
the
directors
might
issue
shares
of
the
company
as
fully
paid
for
the
amount
of
any
dividends
which
the
directors
may
declare
payable
in
money.
On
January
25,
1951,
there
was
a
meeting
of
directors
at
which
the
chairman
reported
that
under
date
of
January
19,
1951,
the
Income
Tax
Department
assessed
the
company
the
amount
of
$37,293.53
on
its
undistributed
income
of
$248,623.58
under
Section
95A
(1)
of
the
Income
Tax
Act
and
that
the
tax
had
been
paid.
The
directors
then
passed
the
following
resolution
:
“Upon
motion
duly
made
and
seconded
it
was
resolved
that
the
Dodds
Medicine
Company
Limited
having
paid
the
tax
payable
under
subsection
(1)
of
Section
95(a)
of
the
Income
Tax
Act
now
elects
to
be
assessed
and
to
pay
a
tax
of
15%
upon
the
sum
of
$39,900,
being
the
aggregate
of
the
dividends
declared
and
paid
by
the
Dodds
Medicine
Company
Limited
in
the
taxation
year
ending
April
30,
1950,
and
that
the
president
is
hereby
authorized
to
take
such
steps
and
execute
such
documents
as
may
be
necessary
to
give
effect
to
this
resolution.”
On
February
9,
1951,
the
directors
passed
the
following
resolution
:
“Upon
motion
duly
made
and
seconded
it
was
resolved
that
a
stock
dividend
of
$240,000
be
and
the
same
is
hereby
declared
payable
forthwith
and
that
there
be
allotted
and
issued
as
fully
paid
and
non-assessable
240,000
three
per
cent
non-cumulative
non-voting
redeemable
preference
shares
of
the
company
of
a
par
value
of
$1
each
to
the
holders
of
the
outstanding
common
shares
of
the
company
in
proportion
to
the
shares
held
by
them
respectively,
namely
at
the
rate
of
8
of
the
said
preference
shares
for
each
one
common
share
standing
in
the
name
of
each
such
holder
of
record
as
at
the
close
of
business
on
February
8,
1951,
and
that
the
said
preference
shares
shall
rank
for
all
dividends
payable
after
February
8,1951.”
It
was
under
this
resolution
that
the
executor
became
entitled
to
and
later
received
the
stock
dividend
in
question
in
these
proceedings,
being
64,000
non-cumulative
redeemable
preference
shares
of
the
capital
stock
of
the
company
authorized
to
be
issued
by
the
by-law
and
supplementary
letters
patent
already
referred
to.
Redemption
of
the
preference
shares
referred
to
was
made
in
part
in
1951,
1952
and
1953
and
by
April
1,
1953,
17,920
of
the
64,000
shares
issued
to
the
executor
had
been
redeemed.
Annual
dividends
were
paid
on
the
preference
shares
outstanding
from
time
to
time,
such
dividends
being
paid
on
May
1,
1951,
May
1,
1952
and
May
1,
1953,
all
in
accordance
with
the
terms
of
the
by-law
under
which
the
preference
shares
were
issued.
Since
the
issue
of
the
preference
shares,
the
balance
sheet
of
the
company
has
shown
the
issued
and
outstanding
common
and
preference
shares
of
the
company
on
the
liability
side
of
the
balance
sheet.
It
will
be
seen
that
by
the
foregoing
acts
of
the
company,
the
company
increased
its
capital
by
the
issue
of
preference
shares;
it
distributed
some
of
those
preference
shares,
which
were
redeemable,
among
its
shareholders
as
a
stock
dividend;
it
in
no
way
committed
itself
to
any
future
redemption
of
the
preference
shares
but
retained
to
itself
the
full
right
to
decide
to
what
extent,
if
at
all,
it
would
ever
redeem
the
preference
shares.
So
far
as
the
company
was
concerned,
it
could
leave
the
preference
shares
outstanding
until
the
company
was
wound
up
and
use
the
capital
represented
by
such
shares
for
such
purposes
as
the
company
might
think
fit.
In
these
circumstances,
I
would
have
thought
that
the
acts
of
the
company
made
it
perfectly
plain
that
it
had
capitalized
that
part
of
its
undistributed
surplus
income
represented
by
the
preference
shares
which
it
issued
as
a
stock
dividend,
and
if
that
be
so,
the
stock
dividend
received
by
the
executor
of
the
last
will
and
testament
of
Stella
Maud
Waters
and
the
redemption
monies
received
by
the
executor
in
respect
of
such
of
those
shares
as
were
redeemed
were
capital
and
not
income.
The
appellant
contends,
however,
that
the
decision
of
this
Court
in
Re
Fleck,
[1952]
O.W.N.
260;
[1952]
C.T.C.
205,
which
affirmed
the
judgment
of
Hogg,
J.A.,
in
Re
Fleck,
[1952]
O.R.
113;
[1952]
C.T.C.
196,
precludes
this
Court
from
holding,
in
the
facts
of
this
case,
that
the
dividends
and
monies
referred
to
were
capital
and
not
income.
In
my
opinion,
the
decision
of
this
Court
in
Re
Fleck
does
not
apply
in
the
facts
of
this
case.
I
do
not
propose
to
discuss
the
numerous
cases
dealing
with
the
question
as
to
whether
a
company
has,
in
the
facts
of
the
particular
case,
capitalized
surplus
income,
as
the
cases
are
fully
and
ably
discussed
in
the
judgment
of
the
learned
Chief
Justice
of
the
High
Court
in
Re
McIntyre,
[1953]
O.R.
910;
[1953]
C.T.C.
372.
To
review
them
in
the
instant
case
would
be
to
repeat
much
of
what
the
learned
Chief
Justice
said
in
the
McIntyre
case.
The
result
of
the
cases,
in
my
opinion,
is
that
it
must
be
decided
in
each
case
whether
the
company
by
its
corporate
acts
so
dealt
with
its
accumulated
surplus
income
as
to
irrevocably
appropriate
it
to
capital
purposes
of
the
company.
I
adopt
the
language
of
Hogg,
J.A.,
in
the
Fleck
case
where
he
said,
at
p.
118
(C.T.C.
atp.
202)
:
“The
conclusive
test
is
whether
or
not
the
company
has
increased
its
capital
in
the
distribution
of
the
surplus
profits.”
A
company
having
surplus
income
may
withhold
it
from
distribution
and
use
it
for
capital
purposes
without
taking
it
into
its
capital
structure
or
may
withhold
it
from
shareholders
and
take
it
into
its
capital
structure
by
issuing
paid
up
stock
in
lieu
of
a
cash
dividend.
In
the
Fleck
case,
the
corporate
acts
of
the
company
show
that
the
company
did
not
withhold
its
accumulated
surplus
income
from
shareholders
nor
did
it
appropriate
such
income
to
any
capital
purpose.
In
doing
what
it
did,
the
company
did
not,
in
fact,
increase
its
capital.
It
did,
in
form,
momentarily
convert
the
surplus
income
into
capital
by
issuing
paid
up
shares
by
way
of
stock
dividend,
but
at
the
same
time
as
it
declared
the
stock
dividend
it
committed
itself
to
immediate
redemption
of
the
shares.
If
one
disregards
the
tax
situation
which,
no
doubt,
prompted
the
company’s
acts
to
take
the
form
they
did,
it
will
be
seen
that
what
the
company
in
reality
did
was
to
distribute
its
accumulated
surplus
income
among
its
shareholders
by
channelling
it
through
its
capital
account.
I
think
all
that
the
Fleck
case
holds
is
that,
in
the
circumstances
which
I
have
mentioned,
the
monies
received
by
the
shareholders
were
income
and
not
capital,
within
the
meaning
of
the
cases
dealing
with
capitalization
of
income.
The
Fleck
case
does
not,
in
my
opinion,
hold
that
in
a
case,
such
as
the
instant
case,
where
the
company
in
issuing
shares
as
a
stock
dividend
does
not
at
the
same
time
commit
itself
to
immediate
redemption,
its
acts
can
be
considered
as
being
anything
else
than
capitalization
of
income,
binding
as
such
upon
the
shareholders.
The
Fleck
case
has
been
considered
and
discussed
by
Judges
of
the
High
Court
in
a
number
of
other
Ontario
cases
but
I
do
not
think
I
need
refer
to
such
other
cases
except
to
say,
with
all
respect
to
any
contrary
view
expressed
in
any
of
such
cases,
that
the
Fleck
case
cannot,
in
my
opinion,
be
distinguished
on
the
ground
that
the
company
concerned
was
a
Dominion
company
and
not
an
Ontario
company.
The
same
corporate
acts
such
as
I
am
considering
should
mean
the
same
thing
in
either
company
except
to
the
extent
that,
if
the
interpretation
of
the
corporate
acts
is
doubtful,
one
should
adopt
an
interpretation
which
is
consistent
with
legality
of
action
as
against
an
interpretation
which
would
indicate
illegal
action.
I
am
not
suggesting
that
in
the
Fleck
case,
or
in
any
of
the
cases
since
that
decision,
the
company
was
doing
anything
illegal.
I
am
saying
that
what
the
company
was
doing
in
the
Fleck
case
and
in
the
instant
case
is
clear.
I
am
not
considering
whether
what
was
done
could
legally
be
done
or
not.
That
is
not
before
this
Court.
Counsel
argues
that
in
a
case
of
this
kind
a
court
can
look
only
at
form
and
must
disregard
substance
and
intention
and
that
if
in
form
the
company
even
for
a
moment
issued
paid
up
shares,
it
capitalized
the
distributable
income
applied
in
payment
of
the
shares.
It
is
also
argued
that
intentions
do
not
matter,
and
reference
is
made
to
the
words
of
Lord
Sumner
in
C.I.R,
v.
Fisher’s
Executors,
[1926]
A.C.
395
at
p.
411,
where
he
said:
“The
only
intention,
that
the
company
has,
is
such
as
is
expressed
in
or
necessarily
follows
from
its
proceedings.
It
is
hardly
a
paradox
to
say
that
the
form
of
a
company’s
resolutions
and
instruments
is
their
substance.”
In
considering
this
appeal,
I
have
endeavoured
to
consider
only
the
corporate
acts
of
the
company
where
I
find
both
the
form
and
substance
as
well
as
the
intention
of
the
company.
I
think,
however,
that
one
must
look
at
the
whole
of
the
form
and
not
just
part
of
it.
When
one
does
so,
it
seems
to
me
to
be
clear
that
in
the
Fleck
case
the
company
was
not
in
fact
capitalizing
its
accumulated
surplus
income
but
that
in
the
instant
case
the
company
was.
I
would,
therefore,
dismiss
the
appeal
but
direct
that
the
costs
of
all
parties
to
the
appeal
be
paid
out
of
the
estate
of
the
deceased,
these
of
the
executor
and
trustee
as
between
solicitor
and
client.